N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-su...

Details N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-su... N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-su...

2011-05-24

2011-05-24

Moore, Susanna (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S222200, C514S211010, C544S003000, C540S544000

Reexamination Certificate

active

07947688

ABSTRACT:
The present invention relates to compounds of Formula (I): wherein R1, R2and R3are as defined in the claims. The compounds have specific affinity for the GABAAreceptor and are therefore useful in the treatment and prevention of diseases modulated by the α1- and α2-GABAAreceptors.

REFERENCES:
patent: 4626538 (1986-12-01), Dusza et al.
patent: 4654347 (1987-03-01), Dusza et al.
patent: 6399621 (2002-06-01), Dusza et al.
patent: 0 129 847 (1985-01-01), None
patent: 0129847 (1985-01-01), None
Hanns Mohler et al.; Neurosciences, pp. 22-25, 2001.
David J. Nutt et al.; British Journal of Psychiatry, vol. 179, pp. 390-396, 2001.
H. Mohler et al.; The Journal of Pharmacology and Experimental Therapeutics; vol. 300, No. 1, pp. 2-8, 2002.
Uwe Rudolph et al.; Nature, vol. 401, pp. 796-800, Oct. 21, 1999.
George, C F P, Lancet, XX, XX, vol. 357, No. 9293, Nov. 10, 2001, pp. 1623-1626.

Affiliated with

Also associated with

Rating

N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-su... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-su..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-su... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2668536